Arbutus biopharma reports q4 loss per share of $2.89

Arbutus reports fourth quarter and year end 2019 financial results, confirms 2020 corporate objectives and provides pipeline update.q4 loss per share $2.89.q4 earnings per share estimate $-0.36 -- refinitiv ibes data.arbutus biopharma - ended year with $90.8 million in cash, cash equivalents & short-term investments, is sufficient to fund operations into mid-2021.arbutus biopharma - expects to utilize between $54 to $58 million of cash & investments to fund operations in 2020.
ABUS Ratings Summary
ABUS Quant Ranking